Skip to main content
All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q1 report for Tiber Creek Health Strategies, Inc. (On Behalf of Genentech, Inc.) on April 18, 2025, reporting $60,000 in lobbying income.

Lobbying for Tiber Creek Health Strategies, Inc. (On Behalf of Genentech, Inc.) · Government relations.

As filed: TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.).

All filings by Tiber Creek Group · Everything Tiber Creek Health Strategies, Inc. (On Behalf of Genentech, Inc.) has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part B Pricing Reform.

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem